InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Ray Sumita, Autre. Officer active across 2 companies, notably Calithera Biosciences, Inc.. Cumulatively, 7 filings have been recorded. Split: 0 buy · 3 sells. Total volume traded: €230k. Activity tracked since 27 October 2021. The latest transaction was filed on 13 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Ray Sumita is a declarant associated with 7 filings in total. Among the 7 most recent sampled filings, they cover the period from 2021-10-29 to 2026-08-17, with EUR 230326 in sales and EUR 0 in purchases. The companies mentioned are Cue Biopharma, Inc., where the listed role is Chief Legal Compliance Officer, and Calithera Biosciences, Inc., where the listed role is See Remarks. The modal transaction nature is Disposal.